mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |